2-(2`,3`,5`-Tri-O-acetyl-b-D-ribofuranosyl)-4-(p-tolylazo)-5-trifluoromethyl-2,4-dihydropyrazol-3-one
n/a
Main Authors: | Zahra Badi, Hussein F. Zohdi, Abdelfattah Haikal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2003-03-01
|
Series: | Molbank |
Subjects: |
Similar Items
-
2-(b-D-Ribofuranosyl)-4-(p-tolylazo)-5-trifluoromethyl-2,4-dihydropyrazol-3-one
by: Zahra Badi, et al.
Published: (2003-03-01) -
Three-dimensional quantitative structure activity relationship (QSAR) of cytotoxic active 3,5-diaryl-4,5-dihydropyrazole analogs: a comparative molecular field analysis (CoMFA) revisited study
by: Hamad Elgazwy Abdel-Sattar S, et al.
Published: (2012-05-01) -
Design, Facile Synthesis and Characterization of Dichloro Substituted Chalcones and Dihydropyrazole Derivatives for Their Antifungal, Antitubercular and Antiproliferative Activities
by: Afzal B. Shaik, et al.
Published: (2020-07-01) -
Synthesis and Antitumor Activity of 5-Trifluoromethyl-2,4- dihydropyrazol-3-one Nucleosides
by: Hussein F.. Zohdi, et al.
Published: (2004-02-01) -
Antimicrobial, Antioxidant, and Anticancer Activities of Some Novel Isoxazole Ring Containing Chalcone and Dihydropyrazole Derivatives
by: Afzal Shaik, et al.
Published: (2020-02-01)